Herpes simplex direct detection of genital lesions: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Lakshmi Gopalakrishnan (talk | contribs)
nocaptcha
10,176 edits
No edit summary
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Bot: Removing from Primary care
 
(8 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
{{Herpes simplex}}
{{Herpes simplex}}


{{CMG}}, '''Associate Editor-In-Chief:''' [[Lakshmi Gopalakrishnan, M.B.B.S.]]
{{CMG}}; {{AE}} [[Lakshmi Gopalakrishnan, M.B.B.S.]]


==Overview==
==Overview==
The confirmation and characterisation of the infection and its type, by direct detection of herpes simplex virus (HSV) in genital lesions, are essential for diagnosis, prognosis, counselling, and management.
The confirmation and characterization of the infection and its type by direct detection of [[herpes simplex virus]] in [[genital]] [[lesions]] is essential for diagnosis, prognosis, counseling, and management. [[Cell culture]] and [[PCR]] are the preferred [[HSV]] tests for people seeking medical treatment for [[Genital ulcer|genital ulcers]] or other [[mucocutaneous]] [[lesions]]. The sensitivity of [[viral culture]] is low, especially for recurrent [[lesions]], and declines rapidly as lesions begin to heal. PCR assays for HSV DNA are more sensitive and are increasingly used in many settings.<ref name="pmid11872854">Scoular A, Gillespie G, Carman WF (2002) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11872854 Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic.] ''Sex Transm Infect'' 78 (1):21-5. PMID: [http://pubmed.gov/11872854 11872854]</ref><ref name="pmid14593592">Wald A, Huang ML, Carrell D, Selke S, Corey L (2003) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14593592 Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.] ''J Infect Dis'' 188 (9):1345-51. [http://dx.doi.org/10.1086/379043 DOI:10.1086/379043] PMID: [http://pubmed.gov/14593592 14593592]</ref> PCR is the test of choice for detecting HSV in spinal fluid for diagnosis of HSV infection of the central nervous system. Viral culture isolates should be typed to determine which type of HSV is causing the infection. Failure to detect HSV by culture or PCR does not indicate an absence of HSV infection, because viral shedding is intermittent. The use of cytologic detection of cellular changes of HSV infection is an insensitive and nonspecific method of diagnosis, both for genital lesions (i.e., Tzanck preparation) and for cervical Pap smears and therefore should not be relied upon.


*'''Isolation of HSV in cell culture''' is the preferred virologic test for patients who seek medical treatment for genital ulcers or other mucocutaneous lesions. However, the sensitivity of culture is low, especially for recurrent lesions, and declines rapidly as lesions begin to heal.
==British Association for Sexual Health and HIV (BASHH) Recommendations<ref>http://www.bashh.org/documents/59/59.pdf</ref>==
 
*PCR assays for HSV-DNA are more sensitive and have been used instead of viral culture; however, '''PCR tests are not FDA-cleared''' for testing of genital specimens. PCR is the test of choice for detecting HSV in spinal fluid for diagnosis of HSV-infection of the central nervous system.
 
*In all patients with newly diagnosed genital herpes, viral culture isolates should be typed to differentiate between HSV-1 and HSV-2. Lack of HSV detection (by culture or PCR) does not indicate a lack of HSV infection, as [[Herpes simplex transmission#Asymptomatic shedding|viral shedding is intermittent]].
 
*The use of cytologic detection of cellular changes of HSV infection is an insensitive and nonspecific method of diagnosis, both for genital lesions (by Tzanck preparation) and for cervical Pap smears, and should not be relied upon.
 
==Recommendations<ref>http://www.bashh.org/documents/59/59.pdf</ref>==
{{cquote|
{{cquote|
*Methods should be used that directly demonstrate HSV in swabs or scrapings from a lesion.
*Methods should be used that directly demonstrate HSV in swabs or scrapings from a lesion.


*Cytological examination ('''Tzanck and Papanicolaou smears''') has modest diagnostic specificity and sensitivity and should not be relied upon for diagnosis.
*Cytological examination (Tzanck and Papanicolaou smears) has modest diagnostic specificity and sensitivity and should not be relied upon for diagnosis.


*'''HSV isolation in cell culture''' is the diagnostic gold standard and the current routine diagnostic method.  
*HSV isolation in cell culture is the diagnostic gold standard and the current routine diagnostic method.  
:*Isolates can be typed and tested for antiviral susceptibility.  
:*Isolates can be typed and tested for antiviral susceptibility.  
:*Virus culture is slow, labour-intensive and expensive.  
:*Virus culture is slow, labor-intensive and expensive.  
:*Specificity is virtually 100%, but levels of virus shedding, quality of specimens, and transport conditions influence sensitivity. First-episode ulcers more often yield the virus than recurrent lesions (82% versus 43%). Average sensitivity is 52% to 93% for vesicles, 41% to 72% for ulcers and 19% to 27% for crusted lesions. Delayed sample processing and lack of specimen refrigeration after collection and during transport significantly reduce the yield of virus culture.
:*Specificity is virtually 100%, but levels of virus shedding, quality of specimens, and transport conditions influence sensitivity. First-episode ulcers more often yield the virus than recurrent lesions (82% versus 43%). Average sensitivity is 52% to 93% for vesicles, 41% to 72% for ulcers and 19% to 27% for crusted lesions. Delayed sample processing and lack of specimen refrigeration after collection and during transport significantly reduce the yield of virus culture.


*'''HSV DNA detection''' by polymerase chain reaction (PCR) increases HSV detection rates by 11 to 71% compared with virus culture. HSV PCR is widely available for testing of cerebrospinal fluid in patients with neurological disease. There have been at least 14 large studies comparing virus culture with PCR for the detection of HSV in muco-cutaneous swabs, together comprising data from over 3,500 patients. These studies demonstrated that the relative sensitivity of virus culture averaged 70% and ranged between 25% and 89%. PCR should be implemented, after local validation, as the preferred diagnostic method for genital herpes.  
*HSV DNA detection by polymerase chain reaction (PCR) increases HSV detection rates by 11 to 71% compared with virus culture. HSV PCR is widely available for testing of cerebrospinal fluid in patients with neurological disease. There have been at least 14 large studies comparing virus culture with PCR for the detection of HSV in muco-cutaneous swabs, together comprising data from over 3,500 patients. These studies demonstrated that the relative sensitivity of virus culture averaged 70% and ranged between 25% and 89%. PCR should be implemented, after local validation, as the preferred diagnostic method for genital herpes.  


:*Unlike virus culture, PCR-based methods do not rely on virus growth and may allow less stringent conditions for sample storage and transport.
:*Unlike virus culture, PCR-based methods do not rely on virus growth and may allow less stringent conditions for sample storage and transport.
Line 31: Line 24:
:*Real-time PCR assays allow detection and typing of HSV in a single reaction tube, with faster turn-around-times (potentially 2 hours) and lower risk of contamination than traditional PCR assays.
:*Real-time PCR assays allow detection and typing of HSV in a single reaction tube, with faster turn-around-times (potentially 2 hours) and lower risk of contamination than traditional PCR assays.


*Viral antigen can be detected by '''direct immunofluorescence assay''' (IFA) using fluorescein-labelled monoclonal antibodies on smears, or by enzyme immunoassay (EIA) on swabs.
*Viral antigen can be detected by direct immunofluorescence assay (IFA) using fluorescein-labelled monoclonal antibodies on smears, or by enzyme immunoassay (EIA) on swabs.


:*IFA shows lower sensitivity (74%) and specificity (85%) than virus culture and cannot be recommended.
:*IFA shows lower sensitivity (74%) and specificity (85%) than virus culture and cannot be recommended.
:*Commercially available EIAs (e.g., HerpChek, PerkinElmer, Belgium) show ≥ 95% specificity and 62% to 100% sensitivity relative to virus culture. Sensitivity may be higher than virus culture for typical presentations and late specimens, but lower for cervical or urethral swabs and recurrent episodes. HerpChek does not differentiate between HSV types.}}
:*Commercially available EIAs (e.g., HerpChek, PerkinElmer, Belgium) show ≥ 95% specificity and 62% to 100% sensitivity relative to virus culture. Sensitivity may be higher than virus culture for typical presentations and late specimens, but lower for cervical or urethral swabs and recurrent episodes. HerpChek does not differentiate between HSV types.}}


==Source==
==External Link==
[http://www.guideline.gov/content.aspx?id=12373&search=herpes+simplex National Guidelines]
[http://www.guideline.gov/content.aspx?id=12373&search=herpes+simplex BASHH guidelines mentioned in National Guideline Clearinghouse]


==References==
==References==
{{reflist|2}}
{{reflist|2}}


{{WH}}
{{WS}}
[[Category:Sexually transmitted diseases]]
[[Category:Viral diseases]]
[[Category:Gynecology]]
[[Category:Dermatology]]
[[Category:Obstetrics]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Sexually transmitted diseases]]
[[Category:Otolaryngology]]
 
[[Category:Urology]]
{{WH}}
{{WS}}

Latest revision as of 22:09, 29 July 2020

Sexually transmitted diseases Main Page

Herpes simplex Microchapters

Home

Patient Information

Genital Herpes
Congenital Herpes

Overview

Classification

Orofacial Infection
Anogenital Infection
Ocular Infection
Herpes Encephalitis
Neonatal Herpes
Herpetic Whitlow
Herpes Gladiatorum
Mollaret's Meningitis

Pathophysiology

Epidemiology and Demographics

Asymptomatic Shedding

Recurrences and Triggers

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Direct detection of Genital Lesions

Treatment

Antiviral Therapy

Overview
Antivirals for First Episode of Genital Herpes
Antivirals for Recurrent Genital Herpes

Primary Prevention

Counseling

Herpes simplex direct detection of genital lesions On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Herpes simplex direct detection of genital lesions

CDC on Herpes simplex direct detection of genital lesions

Herpes simplex direct detection of genital lesions in the news

Blogs on Herpes simplex direct detection of genital lesions

Directions to Hospitals Treating Herpes simplex

Risk calculators and risk factors for Herpes simplex direct detection of genital lesions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lakshmi Gopalakrishnan, M.B.B.S.

Overview

The confirmation and characterization of the infection and its type by direct detection of herpes simplex virus in genital lesions is essential for diagnosis, prognosis, counseling, and management. Cell culture and PCR are the preferred HSV tests for people seeking medical treatment for genital ulcers or other mucocutaneous lesions. The sensitivity of viral culture is low, especially for recurrent lesions, and declines rapidly as lesions begin to heal. PCR assays for HSV DNA are more sensitive and are increasingly used in many settings.[1][2] PCR is the test of choice for detecting HSV in spinal fluid for diagnosis of HSV infection of the central nervous system. Viral culture isolates should be typed to determine which type of HSV is causing the infection. Failure to detect HSV by culture or PCR does not indicate an absence of HSV infection, because viral shedding is intermittent. The use of cytologic detection of cellular changes of HSV infection is an insensitive and nonspecific method of diagnosis, both for genital lesions (i.e., Tzanck preparation) and for cervical Pap smears and therefore should not be relied upon.

British Association for Sexual Health and HIV (BASHH) Recommendations[3]

“
  • Methods should be used that directly demonstrate HSV in swabs or scrapings from a lesion.
  • Cytological examination (Tzanck and Papanicolaou smears) has modest diagnostic specificity and sensitivity and should not be relied upon for diagnosis.
  • HSV isolation in cell culture is the diagnostic gold standard and the current routine diagnostic method.
  • Isolates can be typed and tested for antiviral susceptibility.
  • Virus culture is slow, labor-intensive and expensive.
  • Specificity is virtually 100%, but levels of virus shedding, quality of specimens, and transport conditions influence sensitivity. First-episode ulcers more often yield the virus than recurrent lesions (82% versus 43%). Average sensitivity is 52% to 93% for vesicles, 41% to 72% for ulcers and 19% to 27% for crusted lesions. Delayed sample processing and lack of specimen refrigeration after collection and during transport significantly reduce the yield of virus culture.
  • HSV DNA detection by polymerase chain reaction (PCR) increases HSV detection rates by 11 to 71% compared with virus culture. HSV PCR is widely available for testing of cerebrospinal fluid in patients with neurological disease. There have been at least 14 large studies comparing virus culture with PCR for the detection of HSV in muco-cutaneous swabs, together comprising data from over 3,500 patients. These studies demonstrated that the relative sensitivity of virus culture averaged 70% and ranged between 25% and 89%. PCR should be implemented, after local validation, as the preferred diagnostic method for genital herpes.
  • Unlike virus culture, PCR-based methods do not rely on virus growth and may allow less stringent conditions for sample storage and transport.
  • Real-time PCR assays allow detection and typing of HSV in a single reaction tube, with faster turn-around-times (potentially 2 hours) and lower risk of contamination than traditional PCR assays.
  • Viral antigen can be detected by direct immunofluorescence assay (IFA) using fluorescein-labelled monoclonal antibodies on smears, or by enzyme immunoassay (EIA) on swabs.
  • IFA shows lower sensitivity (74%) and specificity (85%) than virus culture and cannot be recommended.
  • Commercially available EIAs (e.g., HerpChek, PerkinElmer, Belgium) show ≥ 95% specificity and 62% to 100% sensitivity relative to virus culture. Sensitivity may be higher than virus culture for typical presentations and late specimens, but lower for cervical or urethral swabs and recurrent episodes. HerpChek does not differentiate between HSV types.
 ”

External Link

BASHH guidelines mentioned in National Guideline Clearinghouse

References

  1. ↑ Scoular A, Gillespie G, Carman WF (2002) Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect 78 (1):21-5. PMID: 11872854
  2. ↑ Wald A, Huang ML, Carrell D, Selke S, Corey L (2003) Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 188 (9):1345-51. DOI:10.1086/379043 PMID: 14593592
  3. ↑ http://www.bashh.org/documents/59/59.pdf

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Herpes_simplex_direct_detection_of_genital_lesions&oldid=1639305"